|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/69 | |
| C07F 5/04 | |||
| A61P 35/00 |
| (11) | Number of the document | 3471734 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17739381.6 |
| Date of filing the European patent application | 2017-06-08 | |
| (97) | Date of publication of the European application | 2019-04-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/036482 |
| Date | 2017-06-08 |
| (87) | Number | WO 2017/222819 |
| Date | 2017-12-28 |
| (30) | Number | Date | Country code |
| 201662352787 P | 2016-06-21 | US | |
| 201662438073 P | 2016-12-22 | US |
| (72) |
VALIK, Martin, CZ
GABRIEL, Roman, CZ
VRASPIR, Pavel, CZ
LUKAS, David, CZ
|
| (73) |
Teva Pharmaceuticals International GmbH,
Schlüsselstrasse 12, 8645 Jona,
CH
|
| (54) | SOLID STATE FORMS OF IXAZOMIB CITRATE |
| SOLID STATE FORMS OF IXAZOMIB CITRATE |